Liling Mei
- Pharmaceutical Science top 2%
- Molecular Biology
- Biomaterials top 10%
- Public Health, Environmental and Occupational Health
- Organic Chemistry
- Topics
- Advanced Drug Delivery Systems (5 papers)Proteoglycans and glycosaminoglycans research (3 papers)Drug Solubulity and Delivery Systems (2 papers)
- Partner nations
- ChinaUnited KingdomCanada
In The Last Decade
Liling Mei
14 papers receiving 457 citations
Peers
Comparison fields: 5 of 82
- Pharmaceutical Science 196
- Molecular Biology 121
- Biomaterials 106
- Public Health, Environmental and Occupational Health 79
- Organic Chemistry 69
Countries citing papers authored by Liling Mei
This map shows the geographic impact of Liling Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liling Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liling Mei more than expected).
Fields of papers citing papers by Liling Mei
This network shows the impact of papers produced by Liling Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liling Mei. The network helps show where Liling Mei may publish in the future.
Co-authorship network of co-authors of Liling Mei
This figure shows the co-authorship network connecting the top 25 collaborators of Liling Mei. A scholar is included among the top collaborators of Liling Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liling Mei. Liling Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 17 | |
| 3 | 36 | |
| 4 | 26 | |
| 5 | 32 | |
| 6 | 48 | |
| 7 | 53 | |
| 8 | 17 | |
| 9 | 18 | |
| 10 | 103 | |
| 11 | 28 | |
| 12 | 23 | |
| 13 | 34 | |
| 14 | 13 |
About Liling Mei
Liling Mei is a scholar working on Pharmaceutical Science, Oral Surgery and Biomaterials, having authored 14 papers that have together received 465 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (5 papers), Proteoglycans and glycosaminoglycans research (3 papers) and Drug Solubulity and Delivery Systems (2 papers). The work is most often cited by research in Pharmaceutical Science (196 citations), Molecular Medicine (44 citations) and Biomaterials (106 citations). Liling Mei has collaborated with scholars based in China, United Kingdom and Canada. Frequent co-authors include Xin Pan, Chuanbin Wu, Ying Huang, Jintian Chen, Di Huang, Tingting Peng, Yixuan Dong, Zhouhua Wang, Pin Dong and Ge Li. Their work appears in journals such as Journal of Controlled Release, Acta Biomaterialia and Colloids and Surfaces B Biointerfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.